Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (11-20 of 108) with videos related to

Pageof 11
Sort By:
Neuroreport|June 13, 2003
Assessing disease onset and progression in the SOD1 mouse model of ALSPatrick Weydt, So Yon Hong, Michel Kliot, et al.
Journal of Huntington'S Disease|December 15, 2025
β-Blocker effects in huntington's disease: A caution on clinical interpretationN Ahmad Aziz, Daniel Claassen, Åsa Petersén, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 17, 2003
Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosisPatrick Weydt, Michael D Weiss, Thomas Möller, et al.
Glia|September 21, 2004
Increased cytotoxic potential of microglia from ALS-transgenic micePatrick Weydt, Eric C Yuen, Bruce R Ransom, et al.
BMC Neurology|January 4, 2014
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohortPatrick Weydt, Selma M Soyal, G Bernhard Landwehrmeyer, et al.
Teaching and Learning in Medicine|January 11, 2014
Development, implementation, and evaluation of a movie-based curriculum to teach psychopathologyHeiko Graf, Birgit Abler, Patrick Weydt, et al.
Idrugs : the Investigational Drugs Journal|May 22, 2004
Medicinal cannabis: rational guidelines for dosingGregory T Carter, Patrick Weydt, Muraco Kyashna-Tocha, et al.
Neuroreport|November 13, 2004
Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 ratsYiheng Xie, Patrick Weydt, David S Howland, et al.
International Journal of Molecular Sciences|July 29, 2023
Creatine Kinase MB Isoenzyme Is a Complementary Biomarker in Amyotrophic Lateral SclerosisNatsinee Kittipeerapat, Rachel Fabian, Sarah Bernsen, et al.
Neuropharmacology|December 16, 2014
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissueNoemi Pasquarelli, Christoph Porazik, Johannes Hanselmann, et al.
Pageof 11

Showing results (11-20 of 108) with videos related to

Sort By:
Pageof 11
Neuroreport|June 13, 2003
Assessing disease onset and progression in the SOD1 mouse model of ALSPatrick Weydt, So Yon Hong, Michel Kliot, et al.
Journal of Huntington'S Disease|December 15, 2025
β-Blocker effects in huntington's disease: A caution on clinical interpretationN Ahmad Aziz, Daniel Claassen, Åsa Petersén, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 17, 2003
Neuro-inflammation as a therapeutic target in amyotrophic lateral sclerosisPatrick Weydt, Michael D Weiss, Thomas Möller, et al.
Glia|September 21, 2004
Increased cytotoxic potential of microglia from ALS-transgenic micePatrick Weydt, Eric C Yuen, Bruce R Ransom, et al.
BMC Neurology|January 4, 2014
A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohortPatrick Weydt, Selma M Soyal, G Bernhard Landwehrmeyer, et al.
Teaching and Learning in Medicine|January 11, 2014
Development, implementation, and evaluation of a movie-based curriculum to teach psychopathologyHeiko Graf, Birgit Abler, Patrick Weydt, et al.
Idrugs : the Investigational Drugs Journal|May 22, 2004
Medicinal cannabis: rational guidelines for dosingGregory T Carter, Patrick Weydt, Muraco Kyashna-Tocha, et al.
Neuroreport|November 13, 2004
Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 ratsYiheng Xie, Patrick Weydt, David S Howland, et al.
International Journal of Molecular Sciences|July 29, 2023
Creatine Kinase MB Isoenzyme Is a Complementary Biomarker in Amyotrophic Lateral SclerosisNatsinee Kittipeerapat, Rachel Fabian, Sarah Bernsen, et al.
Neuropharmacology|December 16, 2014
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissueNoemi Pasquarelli, Christoph Porazik, Johannes Hanselmann, et al.
Pageof 11